413 related articles for article (PubMed ID: 18347563)
1. Second-line chemotherapy for advanced hormone-refractory prostate cancer.
Garmey EG; Sartor O; Halabi S; Vogelzang NJ
Clin Adv Hematol Oncol; 2008 Feb; 6(2):118-22, 127-32. PubMed ID: 18347563
[TBL] [Abstract][Full Text] [Related]
2. Hormone refractory prostate cancer (HRPC): present and future approaches of therapy.
Di Lorenzo G; De Placido S
Int J Immunopathol Pharmacol; 2006; 19(1):11-34. PubMed ID: 16569343
[TBL] [Abstract][Full Text] [Related]
3. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
Berry W; Eisenberger M
Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in advanced prostate cancer.
Beedassy A; Cardi G
Semin Oncol; 1999 Aug; 26(4):428-38. PubMed ID: 10482185
[TBL] [Abstract][Full Text] [Related]
5. New standards in the chemotherapy of metastatic hormone-refractory prostate cancer.
Sava T; Basso U; Porcaro A; Cetto GL
Expert Rev Anticancer Ther; 2005 Feb; 5(1):53-62. PubMed ID: 15757438
[TBL] [Abstract][Full Text] [Related]
6. Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
Oh WK; Tay MH; Huang J
Cancer; 2007 Feb; 109(3):477-86. PubMed ID: 17186531
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hormone refractory prostate cancer.
Knox JJ; Moore MJ
Semin Urol Oncol; 2001 Aug; 19(3):202-11. PubMed ID: 11561988
[TBL] [Abstract][Full Text] [Related]
8. Actual chemotherapeutical possibilities in hormone-refractory prostate cancer (HRPC) patients.
Prezioso D; Galasso R; Di Martino M; Iapicca G; Annunziata E; Iacono F
Anticancer Res; 2007; 27(2):1095-104. PubMed ID: 17465249
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".
Ryan CJ; Eisenberger M
J Clin Oncol; 2005 Nov; 23(32):8242-6. PubMed ID: 16278479
[TBL] [Abstract][Full Text] [Related]
10. The role of systemic cytotoxic therapy for prostate cancer.
Chang SS; Kibel AS
BJU Int; 2009 Jan; 103(1):8-17. PubMed ID: 19040524
[TBL] [Abstract][Full Text] [Related]
11. Current treatment of advanced prostate cancer.
Ismail M; Gomella LG
Tech Urol; 1997; 3(1):16-24. PubMed ID: 9170220
[TBL] [Abstract][Full Text] [Related]
12. Management of the spectrum of hormone refractory prostate cancer.
Clarke NW
Eur Urol; 2006 Sep; 50(3):428-38; discussion 438-9. PubMed ID: 16797118
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy for non-hormone refractory prostate cancer.
Winquist E
Can J Urol; 2006 Feb; 13 Suppl 1():67-70. PubMed ID: 16526986
[TBL] [Abstract][Full Text] [Related]
14. The current role of chemotherapy in metastatic hormone-refractory prostate cancer.
Petrylak DP
Urology; 2005 May; 65(5 Suppl):3-7; discussion 7-8. PubMed ID: 15885271
[TBL] [Abstract][Full Text] [Related]
15. [What is the objective of second-line chemotherapy after failure of first-line chemotherapy in hormone-resistant metastatic prostate?].
El Demery M; Pouessel D; Avancès C; Iborra F; Rebillard X; Faix A; Ségui B; Delbos O; Ayuso D; Culine S
Prog Urol; 2006 Jun; 16(3):320-3. PubMed ID: 16821344
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapeutic approaches for hormone-refractory prostate cancer.
Stavridi F; Karapanagiotou EM; Syrigos KN
Cancer Treat Rev; 2010 Apr; 36(2):122-30. PubMed ID: 20106600
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology endorsement of the Cancer Care Ontario Practice Guideline on nonhormonal therapy for men with metastatic hormone-refractory (castration-resistant) prostate cancer.
Basch EM; Somerfield MR; Beer TM; Carducci MA; Higano CS; Hussain MH; Scher HI;
J Clin Oncol; 2007 Nov; 25(33):5313-8. PubMed ID: 17925542
[TBL] [Abstract][Full Text] [Related]
18. Management of hormone refractory prostate cancer: current standards and future prospects.
Oh WK; Kantoff PW
J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
[TBL] [Abstract][Full Text] [Related]
19. Secondary hormonal therapy for advanced prostate cancer.
Lam JS; Leppert JT; Vemulapalli SN; Shvarts O; Belldegrun AS
J Urol; 2006 Jan; 175(1):27-34. PubMed ID: 16406864
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for the treatment of hormone-refractory prostate cancer.
Chowdhury S; Burbridge S; Harper PG
Int J Clin Pract; 2007 Dec; 61(12):2064-70. PubMed ID: 17956560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]